1st Quarter - Report

W STRATEGIES, LLC for 23ANDME, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011. Issues related to genetics and Parkinsons' Disease

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3207 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.